Cadre Holdings, Inc. SEC Filing

CDRE filed a Form 144 notice for a proposed sale of 4,132 common shares through UBS Financial Services, with an aggregate market value of $177,676.00.

Accepted by SEC EDGAR 10/24/2025 - 04:02 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

CDRE filed a Form 144 notice for a proposed sale of 4,132 common shares through UBS Financial Services, with an aggregate market value of $177,676.00. The filing lists an approximate sale date of 10/24/2025 on the NYSE.

The shares were acquired as RSUs on 03/18/2024 from the issuer. As context, 40,663,844 shares were outstanding. The filer, identified as Brad Williams, reported sales in the past three months of 4,132 shares on 09/23/2025 for $152,884.00 and 4,132 shares on 10/14/2025 for $165,280.00.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001876053
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cadre Holdings, Inc.
SEC File Number	001-40698
Address of Issuer	13386 INTERNATIONAL PKWY JACKSONVILLE FLORIDA 32218
Phone	(904) 741-5400
Name of Person for Whose Account the Securities are To Be Sold	Williams Brad
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	4132	177676.00	40663844	10/24/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2024	RSU	Issuer			4132	03/18/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brad Williams c/o 13386 INTERNATIONAL PKWY Jacksonville FL 32218	Common	09/23/2025	4132	152884.00
Brad Williams c/o 13386 INTERNATIONAL PKWY Jacksonville FL 32218	Common	10/14/2025	4132	165280.00

144: Remarks and Signature

Remarks
Date of Notice	10/24/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Brad Williams
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)